Asensus Surgical Analyst Ratings
Asensus Surgical Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/22/2023 | 257.4% | Cantor Fitzgerald | → $1 | Reiterates | Overweight → Overweight |
| 08/11/2023 | 614.8% | HC Wainwright & Co. | → $2 | Reiterates | Buy → Buy |
| 05/12/2023 | 614.8% | HC Wainwright & Co. | → $2 | Reiterates | Buy → Buy |
| 03/06/2023 | 614.8% | HC Wainwright & Co. | $3 → $2 | Maintains | Buy |
| 02/22/2023 | 972.19% | HC Wainwright & Co. | → $3 | Reiterates | → Buy |
| 01/10/2023 | 972.19% | HC Wainwright & Co. | → $3 | Reiterates | → Buy |
| 09/08/2022 | 436.1% | Cantor Fitzgerald | → $1.5 | Initiates Coverage On | → Overweight |
| 08/10/2022 | 972.19% | HC Wainwright & Co. | $4 → $3 | Maintains | Buy |
| 05/26/2021 | 1329.59% | HC Wainwright & Co. | → $4 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 2023年08月22日 | 257.4% | 康托·菲茨杰拉德 | →$1 | 重申 | 超重→超重 |
| 2023年08月11日 | 614.8% | HC Wainwright公司 | →$2 | 重申 | 购买→购买 |
| 2023年05月12日 | 614.8% | HC Wainwright公司 | →$2 | 重申 | 购买→购买 |
| 03/06/2023 | 614.8% | HC Wainwright公司 | $3→$2 | 维护 | 买 |
| 02/22/2023 | 972.19% | HC Wainwright公司 | →$3 | 重申 | →购买 |
| 2023年1月10日 | 972.19% | HC Wainwright公司 | →$3 | 重申 | →购买 |
| 09/08/2022 | 436.1% | 康托·菲茨杰拉德 | →$1.5 | 开始承保 | →超重 |
| 2022年08月10日 | 972.19% | HC Wainwright公司 | $4→$3 | 维护 | 买 |
| 2021/05/26 | 1329.59% | HC Wainwright公司 | →$4 | 开始承保 | →购买 |
What is the target price for Asensus Surgical (ASXC)?
Ascount Surgical(ASXC)的目标价格是多少？
The latest price target for Asensus Surgical (AMEX: ASXC) was reported by Cantor Fitzgerald on August 22, 2023. The analyst firm set a price target for $1.00 expecting ASXC to rise to within 12 months (a possible 257.40% upside). 7 analyst firms have reported ratings in the last year.
2023年8月22日，Cantor Fitzgerald报道了Ascount Surgical(美国证券交易所代码：ASXC)的最新目标价。这家分析公司将目标价定为1美元，预计ASXC将在12个月内上涨至(可能上涨257.40%)。去年有7家分析公司公布了评级。
What is the most recent analyst rating for Asensus Surgical (ASXC)?
Ascount Surgical(ASXC)的最新分析师评级是多少？
The latest analyst rating for Asensus Surgical (AMEX: ASXC) was provided by Cantor Fitzgerald, and Asensus Surgical reiterated their overweight rating.
美国证券交易所股票代码：ASXC的最新分析师评级是由坎托·菲茨杰拉德提供的，Ascount Surgical重申了他们的增持评级。
When is the next analyst rating going to be posted or updated for Asensus Surgical (ASXC)?
Ascount Surgical(ASXC)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Asensus Surgical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Asensus Surgical was filed on August 22, 2023 so you should expect the next rating to be made available sometime around August 22, 2024.
分析师在进行了广泛的研究后得出股票评级，其中包括查阅公共财务报表，与Ascount Surgical的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Ascount Surgical的上一次评级是在2023年8月22日提交的，所以你应该预计下一次评级将在2024年8月22日左右提供。
Is the Analyst Rating Asensus Surgical (ASXC) correct?
分析师评级评估外科(ASXC)正确吗？
While ratings are subjective and will change, the latest Asensus Surgical (ASXC) rating was a reiterated with a price target of $0.00 to $1.00. The current price Asensus Surgical (ASXC) is trading at is $0.28, which is within the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的Ascount Surgical(ASXC)评级被重申，目标价在0.00美元至1.00美元之间。Ascount Surgical(ASXC)目前的交易价格为0.28美元，在分析师的预测范围内。